Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-28 Purchase | 2021-06-29 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting | 2,300 | $9 | $20,700 | 2,300 (Indirect) | View |
| 2021-02-22 Sale | 2021-02-24 4:30 pm | Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting | 5,000 | $14.72 | $73,582 | 65,683 (Direct) | View |
| 2021-01-21 Sale | 2021-01-25 4:30 pm | Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting | 6,607 | $14 | $92,498 | 15,212 (Direct) | View |
| 2020-05-11 Sale | 2020-05-12 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting | 7,500 | $16 | $120,000 | 21,071 (Direct) | View |
| 2020-02-24 Sale | 2020-02-26 7:52 pm | Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting | 5,000 | $16.83 | $84,153 | 28,571 (Direct) | View |
| 2020-01-23 Sale | 2020-01-27 4:28 pm | Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting | 5,000 | $17.22 | $86,102 | 66,671 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-01-19 Option Award | 2022-01-21 4:15 pm | N/A 2032-01-18 | Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-02-22 Exercise | 2021-02-24 4:30 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting | 5,000 | $7.84 | 65,683 (Direct) | View |
| 2021-02-22 Exercise | 2021-02-24 4:30 pm | N/A 2029-01-21 | Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting | 5,000 | $0 | 65,683 (Direct) | View |
| 2021-01-25 Option Award | 2021-01-27 4:30 pm | N/A 2031-01-24 | Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting | 40,000 | $0 | 40,000 (Direct) | View |
| 2020-01-23 Option Award | 2020-01-27 4:28 pm | N/A 2030-01-22 | Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting | 33,100 | $0 | 66,671 (Direct) | View |
| 2019-07-18 Option Award | 2019-07-18 5:26 pm | N/A 2029-07-17 | Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. See Remarks | 7,078 | $0 | 7,078 (Direct) | View |
Ownership | 2019-07-17 7:38 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. See Remarks | 0 | $0 | 94,042 (Direct) | View |